{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:06Z","timestamp":1786119306410,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/jcp.0b013e3181b675ba","type":"journal-article","created":{"date-parts":[[2009,9,5]],"date-time":"2009-09-05T03:23:08Z","timestamp":1252120988000},"page":"506-507","source":"Crossref","is-referenced-by-count":4,"title":["A Case of Aripiprazole-Associated Paroxysmal Supraventricular Tachycardia"],"prefix":"10.1097","volume":"29","author":[{"given":"Pei-Chen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chiang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210128","first-page":"49","article-title":"Aripiprazole: a review of its pharmacology and clinical use.","volume":"63","author":"Taylor","year":"2003","journal-title":"Int J Clin Pract"},{"key":"R2-21-20210128","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","article-title":"Pharmacological interventions for acute bipolar mania: a systemic review of randomized placebo-controlled trials.","volume":"9","author":"Smith","year":"2007","journal-title":"Bipolar Disord"},{"issue":"4","key":"R3-21-20210128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1440-1819.2001.00873.x","article-title":"Effects of combination psychotropic drug treatment on heart rate variability in psychiatric patients.","volume":"55","author":"Ikawa","year":"2001","journal-title":"Psychiatry Clin Neurosci"},{"key":"R4-21-20210128","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpsychires.2007.05.002","article-title":"A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg\/day for the treatment of patients with acute exacerbations of schizophrenia.","volume":"41","author":"McEvoy","year":"2007","journal-title":"J Psychiatr Res"},{"key":"R5-21-20210128","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.jcp.0000231267.94210.e5","article-title":"A case of dose-dependent aripiprazole induced conduction disturbance.","volume":"26","author":"Egger","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R6-21-20210128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1819.2008.01833.x","article-title":"Aripiprazole-induced orthostatic hypotension and cardiac arrhythmia.","volume":"62","author":"Torgovnick","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"R7-21-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1540-8159.2004.00388.x","article-title":"Familial atrioventricular nodal reentry tachycardia.","volume":"27","author":"Hayes","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"issue":"20","key":"R8-21-20210128","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1161\/01.CIR.0000068339.04731.4D","article-title":"Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.","volume":"107","author":"Chiou","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"R9-21-20210128","first-page":"1134","article-title":"Absorption, metabolism, and excretion of risperidone in humans.","volume":"21","author":"Mannens","year":"1993","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"R10-21-20210128","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2125.2008.03223.x","article-title":"Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.","volume":"66","author":"Kim","year":"2008","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200910000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:00:56Z","timestamp":1786039256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200910000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181b675ba","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}